ARMISTICE CAPITAL LLC 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-16 2:49 pm Sale | 2022-12-31 | 13G | Addex Therapeutics Ltd ADXN | ARMISTICE CAPITAL LLC | 33,765 4.990% | -168,158![]() (-83.28%) | Filing |
2023-02-14 11:53 am Purchase | 2022-12-31 | 13G | Addex Therapeutics Ltd ADXN | ARMISTICE CAPITAL LLC | 201,923 4.970% | 170,283![]() (+538.19%) | Filing |
2022-02-14 6:33 pm Purchase | 2021-12-31 | 13G | Addex Therapeutics Ltd ADXN | ARMISTICE CAPITAL LLC | 31,640 9.990% | 31,640![]() (New Position) | Filing |